Evidence map›Paper›PMID 42109268›Full record

ArticleRegenerative biomaterials2026

Incorporation of imidazolium chitosan derivative yields scaffolds with enhanced antioxidant, antimicrobial and immunomodulatory properties.

Carolina Muñoz-Núñez, Arantza Barco-Martín, Ketaki Deshpande, Dominik S Schmidt, Lola González-García, Sara Trujillo, Alexandra Muñoz-Bonilla, Marta Fernández-García

Abstract read
In one paragraph

Article in Regenerative biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carolina Muñoz-NúñezInstituto de Ciencia y Tecnología de Polímeros (ICTP-CSIC), Madrid 28006, Spain.
Arantza Barco-MartínInstituto de Ciencia y Tecnología de Polímeros (ICTP-CSIC), Madrid 28006, Spain.
Ketaki DeshpandeINM-Leibniz Institute for New Materials, Saarbrucken 66123, Germany.
Dominik S SchmidtINM-Leibniz Institute for New Materials, Saarbrucken 66123, Germany.
Lola González-GarcíaINM-Leibniz Institute for New Materials, Saarbrucken 66123, Germany.
Sara TrujilloINM-Leibniz Institute for New Materials, Saarbrucken 66123, Germany.
Alexandra Muñoz-BonillaInstituto de Ciencia y Tecnología de Polímeros (ICTP-CSIC), Madrid 28006, Spain.ORCID https://orcid.org/0000-0003-0210-1246
Marta Fernández-GarcíaInstituto de Ciencia y Tecnología de Polímeros (ICTP-CSIC), Madrid 28006, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing biocompatible scaffolds with physicochemical properties suitable for regenerative medicine that also support cell adhesion and proliferation, while reducing local oxidative stress, exhibiting low immunogenicity and antimicrobial properties, represents a key objective in tissue engineering. Chitosan (CS), a biocompatible and biodegradable biopolymer, has attracted considerable attention in recent years as in tissue engineering. Herein, CS scaffolds were functionalized with bioactive antioxidant/antimicrobial molecules and reinforced with natural fillers to enhance these critical properties. The incorporation of a CS derivative containing 1-methylimidazole into CS-based scaffolds, and chitin nanowhiskers as reinforcement, was investigated. The resulting scaffolds exhibited an interconnected porous structure, facilitating nutrient diffusion and cell infiltration. Rheological analysis confirmed a predominantly soft and elastic behavior. Additionally, the antioxidant activity of the scaffolds was evaluated using the DPPH assay, while its antimicrobial effects were confirmed through bacterial inhibition tests. Fibroblast proliferation assays revealed an initial rapid growth phase followed by a stabilization. Immunological studies using macrophages demonstrated an initial activation of the NFκB transcription factor that did not result in the secretion of the pro-inflammatory cytokine IL-6, suggesting a transient macrophage activation. These findings highlight the potential of these CS-based scaffolds for biomedical applications by balancing structural integrity, cell compatibility and controlled immune response.

Indexed as

antimicrobialantioxidantchitosanimmune responsescaffolds

Identifiers

PMID42109268
PMCPMC13151885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.